Search research articles
Contact Us
Filters
Showing results (451-460 of 636) with videos related to
Page
of 64
Sort By:
The New England Journal of Medicine
|
September 1, 2009
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Lars Wallentin, Richard C Becker, Andrzej Budaj, et al.
Circulation
|
February 21, 2014
Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF)
Matthew W Sherwood, James D Douketis, Manesh R Patel, et al.
American Heart Journal
|
December 9, 2019
Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillation
Sean D Pokorney, DaJuanicia N Holmes, Peter Shrader, et al.
American Heart Journal
|
January 2, 2022
Clinical events classification (CEC) in clinical trials: Report on the current landscape and future directions - proceedings from the CEC Summit 2018
Abhinav Sharma, Kenneth W Mahaffey, Charles Michael Gibson, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
September 17, 2018
Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF
Sean T Chen, Anne S Hellkamp, Richard C Becker, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
March 31, 2021
Dosing of Direct Oral Anticoagulants in Patients with Moderate Chronic Kidney Disease in US Clinical Practice: Results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF II)
Larry R Jackson, Peter Schrader, Laine Thomas, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
April 7, 2021
Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial
Jemi Galani, Hillary Mulder, Frank W Rockhold, et al.
Journal of the American College of Cardiology
|
July 19, 2020
2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee
Gordon F Tomaselli, Kenneth W Mahaffey, Adam Cuker, et al.
Circulation
|
November 12, 2023
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria
Brendon L Neuen, Hiddo J L Heerspink, Priya Vart, et al.
The Lancet. Diabetes & Endocrinology
|
November 28, 2024
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
Sunil V Badve, Anika Bilal, Matthew M Y Lee, et al.
Page
of 64
Search research articles
Search
Showing results (451-460 of 636) with videos related to
Sort By:
Page
of 64
The New England Journal of Medicine
|
September 1, 2009
Ticagrelor versus clopidogrel in patients with acute coronary syndromes
Lars Wallentin, Richard C Becker, Andrzej Budaj, et al.
Circulation
|
February 21, 2014
Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF)
Matthew W Sherwood, James D Douketis, Manesh R Patel, et al.
American Heart Journal
|
December 9, 2019
Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillation
Sean D Pokorney, DaJuanicia N Holmes, Peter Shrader, et al.
American Heart Journal
|
January 2, 2022
Clinical events classification (CEC) in clinical trials: Report on the current landscape and future directions - proceedings from the CEC Summit 2018
Abhinav Sharma, Kenneth W Mahaffey, Charles Michael Gibson, et al.
European Heart Journal. Quality of Care & Clinical Outcomes
|
September 17, 2018
Efficacy and safety of rivaroxaban vs. warfarin in patients with non-valvular atrial fibrillation and a history of cancer: observations from ROCKET AF
Sean T Chen, Anne S Hellkamp, Richard C Becker, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions
|
March 31, 2021
Dosing of Direct Oral Anticoagulants in Patients with Moderate Chronic Kidney Disease in US Clinical Practice: Results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF II)
Larry R Jackson, Peter Schrader, Laine Thomas, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
April 7, 2021
Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial
Jemi Galani, Hillary Mulder, Frank W Rockhold, et al.
Journal of the American College of Cardiology
|
July 19, 2020
2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee
Gordon F Tomaselli, Kenneth W Mahaffey, Adam Cuker, et al.
Circulation
|
November 12, 2023
Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria
Brendon L Neuen, Hiddo J L Heerspink, Priya Vart, et al.
The Lancet. Diabetes & Endocrinology
|
November 28, 2024
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials
Sunil V Badve, Anika Bilal, Matthew M Y Lee, et al.
Page
of 64